Pro2Kem

Pro2Kem was a biotechnology instrumentation company based in Dundee, Scotland, that specialized in the development of miniaturized light scattering technology for the characterization of biomolecules. The company's core innovation was a miniaturized instrument that allowed for the analysis of proteins and nucleic acids using extremely small sample volumes, typically less than 5 microliters. This technology was particularly useful in the biopharmaceutical industry for monitoring protein aggregation, studying macromolecular interactions, and optimizing crystallization conditions. In June 2006, Pro2Kem was acquired by Boston Instruments LLC, a group focused on consolidating emerging companies within the molecular spectroscopy and life sciences sectors. The acquisition aimed to integrate Pro2Kem's unique light scattering capabilities into a broader portfolio of analytical tools for drug discovery and development.